Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121247002 | 12124700 | 2 | F | 20130305 | 20160224 | 20160229 | 20160906 | EXP | US-ROCHE-1717684 | ROCHE | 51.84 | YR | F | Y | 54.12000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121247002 | 12124700 | 1 | PS | TARCEVA | ERLOTINIB HYDROCHLORIDE | 1 | Oral | 53728 | 100 | MG | TABLET | BIW | |||||||
| 121247002 | 12124700 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | 545 | MG | SOLUTION FOR INFUSION | ||||||||
| 121247002 | 12124700 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 121247002 | 12124700 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 0 | 135 | MG | QOW | ||||||||
| 121247002 | 12124700 | 5 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 1600 | MG | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121247002 | 12124700 | 1 | Neoplasm malignant |
| 121247002 | 12124700 | 2 | Neoplasm malignant |
| 121247002 | 12124700 | 3 | Cholangiocarcinoma |
| 121247002 | 12124700 | 4 | Neoplasm malignant |
| 121247002 | 12124700 | 5 | Neoplasm malignant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121247002 | 12124700 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121247002 | 12124700 | Neoplasm | |
| 121247002 | 12124700 | Neuropathy peripheral | |
| 121247002 | 12124700 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121247002 | 12124700 | 1 | 20120822 | 20130124 | 0 | |
| 121247002 | 12124700 | 2 | 20130124 | 20130124 | 0 | |
| 121247002 | 12124700 | 4 | 20120725 | 20121107 | 0 | |
| 121247002 | 12124700 | 5 | 20120808 | 20130109 | 0 |